Developed by plastic surgeon and company CEO Dr. Marc Ronert, the treatment addresses common aesthetic concerns such as crepiness, dehydration, and altered fat distribution. The product serves both as a proactive measure for those starting weight-loss regimens and as a corrective solution for individuals already experiencing skin laxity due to significant weight changes or natural aging.

The formula relies on a blend of active components including Heptapeptide-7, Bakuchiol, and Marine Bioactive. Central to its performance is the patent-pending XOSM Technology, a biomimetic delivery system that encapsulates antioxidants like Vitamin C and ectoin to reinforce the skin barrier. Priced at $85, the fragrance-free complex is available through the brand's website and authorized professional providers, arriving on the market following a 12-week clinical study conducted on GLP-1 users.